As per the terms of the agreement, Glenmark has obtained exclusive global marketing and distribution rights to the product upon commercialization Hyderabad: Glenmark Pharmaceuticals Ltd on Monday said it has entered into an agreement with US-based ... Livemint.com, 1 week ago
Glenmark announces tie up for anti cancer drug - Smart Investor, 1 week ago
Glenmark, Particle Sciences enter deal to develop generic cancer drug - Firstpost.com, 1 week ago
2 images for "glenmark generics inc"
Glenmark Pharmaceuticals, Inc., USA (Glenmark) has entered into a strategic development, license and commercialization agreement with Particle Sciences, Inc. to develop and market a generic version of Celgene's Abraxane product paclitaxel protein ...PharmaBiz, 1 week ago Glenmark in strategic development and global licensing agreement with Particle Sciences Moneycontrol.com, 1 week ago Glenmark Pharma gains as subsidiary announces strategic development and global licensing a... KJMC Group, 1 week ago CELGENE : Glenmark announces Strategic Development and Global Licensing Agreement with Particle Sciences, Inc., a Lubrizol Company, for generic ABRAXANE? 4 Traders, 1 week ago
State Bank of India gained 2.7% to Rs.267. The bank has raised Rs.2,100 crore through perpetual bonds at 9% interest rate amid fears that perpetual bond-holders may face a delay in interest repayments with most of the state-owned banks posting ...India Infoline, 3 weeks ago
Reliance Life Sciences, the biopharmaceutical unit of Reliance Industries, has acquired the global rights for biosimilars, or copies, of infliximab from Boston-based Epirus Biopharmaceuticals. Infliximab is used to treat a broad range of medical ...India Infoline, 2 months ago Lupin launches generic oral contraceptive tablets in US and other top pharma news India Infoline, 2 months ago Glenmark Pharma working on proprietary product rollout and other top pharma news India Infoline, 2 months ago Ajanta Pharma launches ulcer drug and other top pharma news [India Infoline News Service] Pharmacy Choice, 2 months ago
Mumbai: Aurobindo, Glenmark and Sun Pharma shares surged by up to 5% on Wednesday after the firms got US health regulator's nod to sell their generic versions of AstraZeneca's cholesterol drug Crestor in the American market. Aurobindo Pharma jumped ...Times of India, 2 months ago Sun, Glenmark, Aurobindo get USFDA nod for cholesterol drug Chandigarh Tribune, 2 months ago Aurobindo, Glenmark jump on USFDA nod to antihyperlipidemic drug Moneycontrol.com, 2 months ago
/PRNewswire/ -- Revenue Forecasting of Originator, Generic and OTC Medicines and Therapy Areas Including CNS, Cardiovascular and Cancer; Exploration of Regional Differences in Healthcare; Discussion of Domestic Manufacturers Including EMS, ...WorldNetDaily, 3 weeks ago
SAN FRANCISCO , July 27, 2016 /PRNewswire/ -- The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative ...WorldNetDaily, 2 months ago Digital Dose Inhaler Market Analysis By Product (Metered Dose Inhaler, Dry Powder Inhaler), By Type (Branded Medication, Generics Medication) And Segment Forecasts to 2024 TickerTech.com, 3 weeks ago Digital Dose Inhaler Market has been anticipated to Account for USD3.56B by 2024 Press Release Ping, 1 month ago
In other news, ICICI Prudential Life's IPO draws 16% bids on Day 1 US markets end flat; Asia opens lower US equities closed mostly flat on Monday after a choppy session, as investors geared up for two key central bank meetings. The Dow Jones ...Livemint.com, 1 week ago Opening Bell | Asian markets open higher; ITC, HDFC Bank in news Livemint.com, 2 months ago
Posted by Equitymaster Indian Indices are trading listless during the post-noon trading session amid weak international markets. Major sectoral indices are trading on a mixed note with stocks from the consumer durables and infrastructure sectors are ...Equitymaster.com, 2 weeks ago
Indoco Remedies Ltd is currently trading at Rs. 342, up by Rs. 20.7 or 6.44% from its previous closing of Rs. 321.3 on the BSE. Indoco Remedies Ltd has informed BSE that USFDA inspected the Company's Goa Plant II from August 31, 2016 to September ...India Infoline, 3 weeks ago Buzzing stocks: BHEL soars, ONGC up India Infoline, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!